Lead, In Vivo Gene Editing Hemoglobinopathies

Scorpion Therapeutics seeks a senior leader to drive lead discovery and translational research for in vivo gene editing therapies targeting hemoglobinopathies. The role spans target selection, preclinical work, IND-enabling studies, and Phase 1/2 trial readiness.

Responsibilities include shaping scientific strategy, guiding in vitro/ex vivo/in vivo studies, supporting candidate optimization, and leading cross-functional teams toward nomination of a development candidate.

This role, Lead, In Vivo Gene Editing for Hemoglobinopathies at Vertex Pharmaceuticals LLC, could be your next career step.

We would love to welcome a new Lead, In Vivo Gene Editing for Hemoglobinopathies to our organisation in Boston, MA, United States.

For the Lead, In Vivo Gene Editing for Hemoglobinopathies position at Vertex Pharmaceuticals LLC, we are reviewing applications now.

Step into the Lead, In Vivo Gene Editing for Hemoglobinopathies role at Vertex Pharmaceuticals LLC in Boston, MA, United States and grow with us.